Bonehealth in children and adolescents with hematologic/oncologic diseases

Bonehealth in children and adolescents with hematologic/oncologic diseases - Bone OK

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003636

Enrollment

1000

Registered

2012-08-28

Start date

2012-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

complete spectrum of paediatric oncologic diseases.chronic haematological diseases (sickle cell, thalassemia) C00-C97 D55-D59

Interventions

Group 1: Aim of the study is to investigate the impact of chemotherapy and oncologic/hematologic disease on bone health. As part of the visit the patient will undergo a thorough physical examination.

Eligibility

Sex/Gender

All

Age

No minimum to 21 Years

Inclusion criteria

Inclusion criteria: oncologic/hematologic disease

Exclusion criteria

Exclusion criteria: symptomatic anemia

Design outcomes

Primary

Measure	Time frame
Risk of osseous morbidity in cancer survivors Risk of osseous morbidity in patients with chronic haematological disease	—

Secondary

Measure	Time frame
Influence of life style parameters on bone health. correlation of osteocalcin levels and osseous morbidity.	—

Countries

Germany

Contacts

Public ContactMichael Schündeln

Oberarzt Abteilung für Hämatologie und OnkologieKinderklinik IIIUniversitätsklinikum Essen

michael.schuendeln@uk-essen.de0201 7233350

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026